Know Cancer

or
forgot password
  • cancer clinical trials in new haven, CT

  • Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Lung Cancer
    Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Cardiac Toxicity, Lymphoma
    Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Leukemia
    Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Leukemia
    Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Leukemia
    Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Leukemia, Lymphoma
    The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children
    Yale Univ Med School
    New Haven, Connecticut 06504
    HIV Infections, HIV Wasting Syndrome, Lipodystrophy
    Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma, Retinoblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Beta-Thalassemia
    Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Sarcoma
    Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Leukemia
    Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Esophageal Cancer, Gastric Cancer
    Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
    Hospital of St. Raphael
    New Haven, Connecticut 06511
    Stage III Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage IVA Adult Soft Tissue Sarcoma, Stage IIB Adult Soft Tissue Sarcoma, Stage IIC Adult Soft Tissue Sarcoma
    Lobradimil and Carboplatin in Treating Children With Brain Tumors
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Brain and Central Nervous System Tumors
    Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia
    Yale Comprehensive Cancer Center at Yale University School of Medicine
    New Haven, Connecticut 06520-8064
    Leukemia
    Combination Chemotherapy in Treating Patients With Advanced Cancer
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Unspecified Adult Solid Tumor, Protocol Specific
    Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients
    Yale University
    New Haven, Connecticut 06520
    Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma, Mixed Oligoastrocytoma, Malignant Astrocytoma
    VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Lymphoma, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Metastatic Cancer
    Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus
    Yale Comprehensive Cancer Center at Yale University School of Medicine
    New Haven, Connecticut 06520-8064
    Sarcoma
    Melatonin and Radiation Therapy in Treating Patients With Brain Metastases
    Hospital of St. Raphael
    New Haven, Connecticut 06511
    Metastatic Cancer, Radiation Toxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Colorectal Cancer
    Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Cervical Cancer
    Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
    Yale Comprehensive Cancer Center

    Trial Locations
    Yale Comprehensive Cancer Center
    Hospital of St. Raphael
    Carcinoma of Unknown Primary
    An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer
    Yale University
    New Haven, Connecticut 06520
    Breast Neoplasms, Breast Cancer, Metastasis
    Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Non-Small Cell Lung Cancer
    Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
    Yale Comprehensive Cancer Center

    Trial Locations
    Yale Comprehensive Cancer Center
    Hospital of Saint Raphael
    Cachexia, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific
    Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia
    Yale Comprehensive Cancer Center at Yale University School of Medicine
    New Haven, Connecticut 06520-8064
    Leukemia
    CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Multiple Myeloma
    Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
    Yale Comprehensive Cancer Center at Yale University School of Medicine
    New Haven, Connecticut 06520-8064
    Pancreatic Cancer
    Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Hepatitis B
    Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Melanoma, Malignant Metastatic Melanoma
    A Dose Finding Phase I Trial of the Combination of Topotecan and PS-341, a Novel Proteasome Inhibitor, in Advanced Malignancies
    Yale University
    New Haven, Connecticut 06520
    Unspecified Adult Solid Tumor, Protocol Specific
    Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma
    Yale University
    New Haven, Connecticut 06520
    Hepatocellular Carcinoma, Liver Cancer
    The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
    Yale University School of Medicine - Department of Neurosurgery
    New Haven, Connecticut 06520
    Glioblastoma Multiforme
    Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Breast Cancer, Metastases
    Computed Tomographic Colonography in Screening Healthy Participants for Colorectal Cancer
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Colorectal Cancer
    Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Endometrial Cancer
    Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Yale Comprehensive Cancer Center at Yale University School of Medicine
    New Haven, Connecticut 06520-8064
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Cervical Cancer
    A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Soft Tissue Sarcoma
    XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Biliary Tract Cancer
    Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis
    The Savin Center P.C.
    New Haven, Connecticut 06511
    Psoriatic Arthritis
    Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
    Yale Comprehensive Cancer Center at Yale University School of Medicine
    New Haven, Connecticut 06520-8064
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
    Yale University School of Medicine - Oncology Outpatient Clinic
    New Haven, Connecticut 06520
    Melanoma, Metastases
    Views of Cancer Patients Regarding Financial Conflicts of Interest
    Yale University
    New Haven, Connecticut 06520
    Neoplasms
    Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Lymphoma, Non-Hodgkin
    Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Multiple Myeloma
    Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Lymphoma, Leukemia, Cancer
    A Study of Anal Cancer Development in HIV Infected People
    Yale University

    Trial Locations
    Yale University
    CRI-Brooklin
    CRI-Springfield
    HIV Infections, Anus Neoplasms